Interim RELIANCE registry data of FMF patients treated with Canakinumab shows efficacy and safety of long-term tx including w/ dose adjustments. Abs 0138 #ACR22 @RheumNow
Patients with Familial Mediterranean Fever (FMF) Under Canakinumab Treatment - Long-term Efficacy and Safety Interim Data of the RELIANCE Registry - ACR Meeting Abstracts
